CIK 0001921865 · <br>Emerging growth company
ASP Isotopes Inc.
Sign in to watch- Ticker
- ASPI
- Exchange
- Nasdaq
- Industry
- Miscellaneous Chemical Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 872618235
- Phone
- 202-756-2245
- Business address
- 2200 ROSS AVENUE, SUITE 4575E, DALLAS, TX, 75201
- 4 Planned sale Chairman and CEO sold 251,275 shares at an average $7.98 ($2,004,337)
- 4 Grant or award Chief Operating Officer acquired 800,000 shares (grant or award)
- 4 Grant or award EVP, Gen Counsel, Secretary acquired 400,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 840,000 shares (grant or award)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 10-K/A Report 10-K/A
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale COO sold 22,500 shares at $5.21 ($117,113)
- 4 Planned sale Chief Financial Officer sold 23,124 shares at $5.48 ($126,673)
- 4 Planned sale Director sold 11,642 shares at $5.21 ($60,597)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 4 of 21 · 407 filings